Recursion Pharmaceuticals Stock Jumps on Strong Morning Momentum

NEW YORK – Shares of Recursion Pharmaceuticals, Inc. (Nasdaq: RXRX), a clinical-stage biotechnology company that combines AI with biology, are seeing a notable rally in morning trading. As of 10:47 AM EDT, the stock is trading at 0.16 or +3.28% for the session.
The stock’s intraday chart reveals a powerful move that began shortly after the market opened. After an initial dip to 5.22**. The stock is now consolidating near these highs, a sign that bulls are attempting to maintain control. Trading volume is active, with nearly 7.5 million shares exchanged, indicating heightened interest in the name.
Key data for RXRX:
-
Previous Close: $5.03
-
Day’s Range: $5.01 – $5.22
Advertisement -
52-Week Range: $3.79 – $12.36
-
Analyst 1-Year Target Estimate: $7.14
Should You Buy or Sell RXRX Stock Today?
The stock’s sharp upward move presents a classic scenario for traders and investors.
For Potential Buyers: The strong bullish reversal after the morning dip is a technically positive signal. For investors who believe in the long-term potential of AI in drug discovery, this could represent a renewed interest in the sector. The analyst price target of $7.14 suggests significant potential upside from the current level, making it attractive for those with a higher risk tolerance.
For Current Holders (Sellers): As is common with clinical-stage biotech companies that are not yet profitable (EPS of -$1.80), stock rallies can be volatile. The quick spike to the day’s high offers an opportunity for short-term traders to lock in profits. The stock is now testing resistance at the $5.22 level, and a failure to break through could lead to a pullback.
Final Opinion
Recursion Pharmaceuticals is exhibiting strong positive momentum today. The buying pressure that drove the stock up from its morning low is significant and suggests a shift in sentiment. While the company is speculative by nature, the potential upside highlighted by analyst targets is compelling.
The key level for traders to watch for the remainder of the day is the session high of $5.22. A sustained break above this price could signal a further move higher. Conversely, if it fails to hold its gains, it may pull back to find support. The stock’s performance today is a clear indicator that investor focus on AI-driven biotech remains strong.